— Know what they know.
Not Investment Advice
Also trades as: NXG.V (TSXV) · $vol 0M

NEGXF OTC

NexgenRx Inc.
1W: -2.8% 1M: +37.5% 3M: +35.4% YTD: +57.1% 1Y: +120.0% 3Y: +131.1% 5Y: +242.6%
$0.44
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Healthcare Information Services · Tech Score Strong Buy · Power 72 · $31.3M mcap · 45M float · 0.025% daily turnover · Short 100% of daily vol

Balance Sheet Trends

Total Assets
$30M +0.9% ▲
5Y CAGR: +7.0%
Total Liabilities
$23M +1.6% ▲
5Y CAGR: +2.8%
Shareholders Equity
$8M -1.2% ▼
5Y CAGR: +32.2%
Cash & Investments
$2M -9.1% ▼
5Y CAGR: -34.7%
Total Debt
$534K +15.6% ▲
5Y CAGR: -33.6%
Net Debt
-$1M +17.2% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$18M$20M$17M$2M$2M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$18M$20M$17M$2M$2M
Net Receivables$389K$611K$551K$778K$874K
Inventory$0$0$1$0$0
Other Current Assets$22M$23M$21M$20M$22M
Total Current Assets$18M$21M$18M$23M$25M
Property, Plant & Equip.$693K$507K$828K$809K$826K
Goodwill & Intangibles$8M$8M$7M$4M$4M
Long-Term Investments$0-$4M-$1M$0$181K
Other Non-Current Assets-$2M$2M-$607K$144K$87K
Total Non-Current Assets$7M$9M$8M$7M$6M
Total Assets$25M$30M$26M$30M$30M
— Liabilities —
Accounts Payable$1M$2M$1M$1M$504K
Short-Term Debt$986K$0$0$0$0
Deferred Revenue$33K$33K$3$0$0
Other Current Liabilities$17M$18M$15M$20M$22M
Total Current Liabilities$19M$20M$16M$22M$22M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.-$199K-$46K-$138K$0$0
Total Non-Current Liabilities$728K$173K$387K$402K$427K
Total Liabilities$20M$20M$17M$22M$23M
— Equity —
Common Stock$19M$19M$19M$4M$4M
Retained Earnings-$19M-$16M-$16M-$2M-$2M
Accumulated OCI$0$24M$23M$0$0
Total Stockholders Equity$6M$10M$9M$8M$8M
Total Liabilities & Equity$25M$30M$26M$30M$30M
— Key Metrics —
Total Debt$1M$405K$429K$462K$534K
Net Debt-$17M-$20M-$17M-$1M-$1M
Total Investments$0-$4M-$1M$0$181K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms